Both medications affect appetite, fullness, digestion, and metabolic signaling
Janumet is a variation of Januvia which is a mix of sitagliptin and metformin (another drug that treats diabetes)
Clinical evidence from the STEP trials demonstrated that participants using semaglutide lost between 15 and 22 percent of their starting body weight over approximately one year, though results depend on individual factors including genetics, adherence, and metabolic response
GLP-1s feel like theyre everywhere
Various issues, including blood sugar response, vascular effects, blood pressure, and moreas well as the more commonly discussed gastrointestinal problems, such as nausea, vomiting, and diarrheamay mean that your weight loss drug pathway cannot follow the optimal route